Common use of Surface Restrictions Clause in Contracts

Surface Restrictions. Surface hereby covenants that it and its Affiliates shall not seek to or actually clinically develop or commercialize any Program-Benefited Antibody, or product containing either of the foregoing (other than the activities permitted hereunder during the Research Term and the Evaluation Term for the purpose of determining whether or not to exercise an Option for such Target), without first executing the Commercial Option with Adimab with respect to the applicable Target.

Appears in 2 contracts

Sources: Development and Option Agreement (Coherus BioSciences, Inc.), Development and Option Agreement (Surface Oncology, Inc.)